Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) shares are trending on Thursday.
Shares of the Massachusetts-based biotech company, which gained 4.31% during Wednesday’s regular session, tapered down 0.21% in after-hours trading to $460.16.
According to Benzinga Pro data, VRTX closed at $461.14 on Wednesday.
Earnings Release Set For Feb. 12
Vertex announced on Tuesday that it will release its fourth-quarter and full-year 2025 financial results on Feb. 12 after the market closes. A conference call and webcast are scheduled for 4:30 p.m. ET.
Analysts are projecting earnings per share of $4.85 and quarterly revenue of $3.17 billion.
In November, Vertex reported third-quarter earnings per share of $4.80, surpassing estimates of $4.35, with revenue totaling $3.08 billion.
Directors Acquire Stock Units
Directors Bruce I. Sachs and Suketu Upadhyay acquired deferred stock units on Jan. 15, according to two Securities and Exchange Commission filings dated Tuesday.
Sachs …